Suggamadex and Fast-track Cardiac Anesthesia in a Developing Country

Completed

• Conditions: Suggamadex; Surgery for Congenital Heart Disease
• Interventions: Procedure: Surgery

• Registration Number: NCT02704351
• Lead Sponsor: Joseph D. Tobias

Brief Summary

The purpose of this study is to retrospectively review our preliminary experience during a surgical trip to Tuxtla, Mexico, using suggamadex to reverse neuromuscular blockade following CPB and cardiac surgery for repair of CHD in infants and children.

Detailed Description

Not available

Study Timeline

• Study Start: 2016-02
• Study First Submitted: 2016-03-04
• Study First Submitted QC: 2016-03-04
• Study First Posted: 2016-03-10
• Primary Completion: 2016-08
• Study Completion: 2016-08
• Status Verified: 2023-05
• Last Update Submitted: 2023-05-03
• Last Update Posted: 2023-05-06

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 14

Inclusion Criteria

• Patients who underwent cardiac surgery and cardiopulmonary bypass in Tuxtla, Mexico in September 2015.

Exclusion Criteria

• None

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Sugammadex group	Surgery	sugammadex to reverse neuromuscular blockade following cardiac surgery

Primary Outcome Measures

Name	Time	Method
Clinical effects of the reversal of neuromuscular blockade with suggamadex following surgery for congenital heart disease in infants and children	After cardiac surgery, on average within 5 minutes

Trial Locations

Locations (1)

Nationwide Children's Hospital; 🇺🇸 Columbus, Ohio, United States